Guardant Health entered into an Open Market Sale Agreement SM with Jefferies as the agent with respect to an at-the-market offering program under which the company may offer and sell, from time to time at its sole discretion, shares of the company’s common stock having aggregate gross proceeds of up to $400.0M through the agent, acting as sales agent. Any shares to be offered and sold under the sales agreement will be issued and sold pursuant to the company’s shelf registration statement on Form S-3, which was filed with the U.S. Securities and Exchange Commission on May 22, 2023 and became effective immediately upon filing, the company noted in a filing.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GH:
- Guardant Health price target raised to $40 from $32 at UBS
- Guardant Health price target raised to $34 from $30 at Piper Sandler
- Cathie Wood’s ARK Investment bought 127K shares of Guardant Health today
- Guardant Health price target raised to $37 from $28 at Craig-Hallum
- Guardant Health price target raised to $45 from $40 at Citi